CoChat

Leptin Signaling in Obesity and Colorectal Cancer

Open access
Socol, Claudia Terezia, Chira, Alexandra, Martinez-Sanchez, Maria Antonia, Nuñez-Sanchez, Maria Angeles, Maerescu, Cristina Maria, Mierlita, Daniel, Rusu, Alexandru Vasile, Ruiz-Alcaraz, Antonio Jose, Trif, Monica, Ramos-Molina, Bruno · 2022 · International Journal of Molecular Sciences
Cited by 91

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Obesity and colorectal cancer (CRC) are among the leading diseases causing deaths in the world, showing a complex multifactorial pathology. Obesity is considered a risk factor in CRC development through inflammation, metabolic, and signaling processes. Leptin is one of the most important adipokines related to obesity and an important proinflammatory marker, mainly expressed in adipose tissue, with many genetic variation profiles, many related influencing factors, and various functions that have been ascribed but not yet fully understood and elucidated, the most important ones being related to energy metabolism, as well as endocrine and immune systems. Aberrant signaling and genetic variations of leptin are correlated with obesity and CRC, with the genetic causality showing both inherited and acquired events, in addition to lifestyle and environmental risk factors; these might also be related to specific pathogenic pathways at different time points. Moreover, mutation gain is a crucial factor enabling the genetic process of CRC. Currently, the inconsistent and insufficient data related to leptin’s relationship with obesity and CRC indicate the necessity of further related studies. This review summarizes the current knowledge on leptin genetics and its potential relationship with the main pathogenic pathways of obesity and CRC, in an attempt to understand the molecular mechanisms of these associations, in the context of inconsistent and contradictory data. The understanding of these mechanisms linking obesity and CRC could help to develop novel therapeutic targets and prevention strategies, resulting in a better prognosis and management of these diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23094713

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 91

Metadata

Authors
Socol, C. T., Chira, A., Martinez-Sanchez, M. A., Nuñez-Sanchez, M. A., Maerescu, C. M., Mierlita, D., Rusu, A. V., Ruiz-Alcaraz, A. J., Trif, M., & Ramos-Molina, B.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-04-24
Volume
23
Issue
9
Pages
4713
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4224308617
Cited by
91
References
21
FWCI
11.79
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leptin Signaling in Obesity and Colorectal Cancer. https://app.cochat.ai/papers/10.3390/ijms23094713
The paper
Socol, C. T., Chira, A., Martinez-Sanchez, M. A., Nuñez-Sanchez, M. A., Maerescu, C. M., Mierlita, D., Rusu, A. V., Ruiz-Alcaraz, A. J., Trif, M., & Ramos-Molina, B. (2022). Leptin Signaling in Obesity and Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23094713

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.